Cholera overview: Difference between revisions

Jump to navigation Jump to search
Line 22: Line 22:


==Risk Factors==
==Risk Factors==
Certain factors have been found to be associated with an increased risks of cholera. Among these are [[immunocompromised|decreased immunity]], decreased gastric pH, certain blood groups (people with type O blood are most prone, while people with type AB blood are least prone), and [[genetics]] are the most commonly associated factors.<ref name="pmid4014172">{{cite journal| author=Glass RI, Holmgren J, Haley CE, Khan MR, Svennerholm AM, Stoll BJ et al.| title=Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. | journal=Am J Epidemiol | year= 1985 | volume= 121 | issue= 6 | pages= 791-6 | pmid=4014172 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4014172  }} </ref><ref name="pmid10892490">{{cite journal| author=Rabbani GH, Greenough WB| title=Food as a vehicle of transmission of cholera. | journal=J Diarrhoeal Dis Res | year= 1999 | volume= 17 | issue= 1 | pages= 1-9 | pmid=10892490 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10892490  }} </ref><ref name="pmid19212328">{{cite journal| author=Larocque RC, Sabeti P, Duggal P, Chowdhury F, Khan AI, Lebrun LM et al.| title=A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. | journal=Genes Immun | year= 2009 | volume= 10 | issue= 3 | pages= 267-72 | pmid=19212328 | doi=10.1038/gene.2009.2 | pmc=2672110 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19212328  }} </ref> At particular risk are people residing in over-populated communities and refugee settings characterized by poor sanitation, unsafe drinking water, and consequently increased person-to-person transmission.<ref name=Cholera-outbreak> World Health Organization. Assessing the Outbreak response and improving preparedness (2004) http://apps.who.int/iris/bitstream/10665/43017/1/WHO_CDS_CPE_ZFk_2004.4_eng.pdf</ref>
Certain factors have been found to be associated with an increased risks of cholera. Among these are [[immunocompromised|decreased immunity]], decreased gastric pH, certain blood groups (people with type O blood are most prone, while people with type AB blood are least prone), and [[genetics]] are the most commonly associated factors.<ref name="pmid4014172">{{cite journal| author=Glass RI, Holmgren J, Haley CE, Khan MR, Svennerholm AM, Stoll BJ et al.| title=Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. | journal=Am J Epidemiol | year= 1985 | volume= 121 | issue= 6 | pages= 791-6 | pmid=4014172 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4014172  }} </ref><ref name="pmid10892490">{{cite journal| author=Rabbani GH, Greenough WB| title=Food as a vehicle of transmission of cholera. | journal=J Diarrhoeal Dis Res | year= 1999 | volume= 17 | issue= 1 | pages= 1-9 | pmid=10892490 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10892490  }} </ref><ref name="pmid19212328">{{cite journal| author=Larocque RC, Sabeti P, Duggal P, Chowdhury F, Khan AI, Lebrun LM et al.| title=A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. | journal=Genes Immun | year= 2009 | volume= 10 | issue= 3 | pages= 267-72 | pmid=19212328 | doi=10.1038/gene.2009.2 | pmc=2672110 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19212328  }} </ref> At particular risk are people residing in over-populated communities and refugee settings characterized by poor sanitation, unsafe drinking water, and, consequently, increased person-to-person transmission.<ref name=Cholera-outbreak> World Health Organization. Assessing the Outbreak response and improving preparedness (2004) http://apps.who.int/iris/bitstream/10665/43017/1/WHO_CDS_CPE_ZFk_2004.4_eng.pdf</ref>


==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==

Revision as of 15:43, 7 October 2016

Cholera Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholera from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Cholera overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholera overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholera overview

CDC on Cholera overview

Cholera overview in the news

Blogs on Cholera overview

Directions to Hospitals Treating Cholera

Risk calculators and risk factors for Cholera overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Overview

Cholera is an infection of the small intestine caused by the bacterium Vibrio cholerae. The main symptoms are profuse, watery diarrhea and vomiting. Transmission occurs primarily by drinking water or eating food that has been contaminated by the feces of an infected person, including one with no apparent symptoms. The severity of the diarrhea and vomiting can lead to rapid dehydration and electrolyte imbalance, and, in some cases, death. The primary treatment is oral rehydration therapy, typically with oral rehydration solution (ORS), to replace water and electrolytes. If this is not tolerated or does not provide fast enough improvement, intravenous fluids can also be used. Antibacterial drugs are beneficial in those with severe forms of the disease, as they shorten the duration and mitigate the severity of cholera. Worldwide, cholera affects 3–5 million people and causes 100,000–130,000 deaths a year. Cholera was one of the earliest infections to be studied by epidemiological methods.

Historical Perspective

The cholera bacterium was originally isolated in 1855 by Italian anatomist Filippo Pacini, but its exact nature and his results were not widely known. One of the major contributions to fighting cholera was made by the physician and pioneer medical scientist John Snow (1813–1858), who, in 1854, identified a link between cholera and contaminated drinking water.[1] Dr. Snow proposed a microbial origin for epidemic cholera in 1849.

Pathophysiology

Most of the V. cholerae bacteria cannot survive the highly acidic conditions of the human stomach.[2] The few bacteria that do manage to survive the stomach's acidity conserve their energy and stored nutrients during passage through the stomach by largely shutting down protein production and restarting production in the more favorable environment of the small intestine. The toxins that interact with mechanisms of the host cell pump chloride ions into the small intestine, creating an ionic pressure that prevents sodium ions from entering the cell. The chloride and sodium ions create a saltwater environment in the small intestine, which, through osmosis, can pull up to six liters of water per day through the intestinal cells. This effect is responsible for the high frequency of diarrhea that is characteristic of cholera. The host can rapidly become severely dehydrated if an appropriate mixture of dilute saltwater and sugar is not taken to replace the blood's water and salts lost in the diarrhea.

Causes

Cholera is a severe diarrheal disease caused by the gram negative bacterium Vibrio cholerae.[3] Transmission to humans occurs through the ingestion of contaminated water or food. The major reservoir for cholera was long assumed to be humans, but some evidence suggests that it may be the aquatic environment.

Differentiating Cholera from other Diseases

Cholera must be differentiated from other infectious causes of diarrhea such as rotavirus, E. coli, amebic dysentery, and giardiasis. It should also be differentiated from some non-infectious causes of diarrhea such as VIPoma, tubulovillous adenoma, and food poisoning.

Epidemiology and Demographics

Cholera affects an estimated 3-5 million people worldwide and causes 100,000-130,000 deaths a year as of 2010. Mortality due to cholera occurs mainly in the developing world.[4] In the early 1980s, death rates are believed to have been greater than 3 million a year. It is difficult to calculate exact numbers of cases, as many go unreported due to concerns that an outbreak may have a negative impact on the tourism of a country.[5] Cholera remains both epidemic and endemic in many areas of the world. Although much is known about the mechanisms behind the spread of cholera, this has not led to a full understanding of what makes cholera outbreaks happen in some places but not others. Inadequate or nonexistent treatment of human feces and drinking water greatly facilitate the spread of cholera, while bodies of water can serve as reservoirs and seafood shipped over long distances can spread the disease. Cholera was not observed in the Americas for most of the 20th century, but it reappeared towards the end of that century and seems likely to persist.[6]

Risk Factors

Certain factors have been found to be associated with an increased risks of cholera. Among these are decreased immunity, decreased gastric pH, certain blood groups (people with type O blood are most prone, while people with type AB blood are least prone), and genetics are the most commonly associated factors.[7][8][9] At particular risk are people residing in over-populated communities and refugee settings characterized by poor sanitation, unsafe drinking water, and, consequently, increased person-to-person transmission.[10]

Natural History, Complications and Prognosis

Cholera can cause a severe diarrheal disease ( acute and huge loss of water and electrolytes).[3] The incubation period is very short (2 hours to 5 days), so as the result the number of cases can rise extremely quickly. Delayed initiation of rehydration therapy or inadequate rehydration may lead to hypotension and electrolyte imbalance (mostly hypokalemia). If dehydration left untreated, it may lead to hypotension which can result in renal failure, hypovolemic shock, coma and death. If hypokalemia left untreated, it can lead to nephropathy and focal myocardial necrosis. Among the children, hypoglycemia is common and can lead to seizures.[10] If people with cholera are treated quickly and properly, the mortality rate is less than 1%. However, with untreated cholera, the mortality rate rises to 50–60%.[11][12]

Diagnosis

History and Symptoms

Patient may give a history of consumption of contaminated food or water, and travel to an endemic area. The symptoms usually develop within 24-48 hour of consumption of contaminated food. Patient presents with sudden onset, painless, odorless, rice watery large volume stool, abdominal cramps, vomiting and fever. If the severe diarrhea and vomiting are not aggressively treated, they can, within hours, result in life-threatening dehydration and electrolyte imbalances. The typical symptoms of dehydration include dizziness ( due to low blood pressure), wrinkled hands (poor skin turgor) , sunken eyes, mucle cramps (decreased potassium), and decreased urine output.

Physical Examination

The signs on physical examination depends on the level of dehydration and patient may present with tachycardia, postural hypotension, somnolence, dry mucous membrane, sunken eyes,oliguria. If the severe diarrhea and vomiting are not aggressively treated, they can, within hours, result in life-threatening dehydration and electrolyte imbalances. The typical symptoms of dehydration include dizziness ( due to low blood pressure), wrinkled hands (poor skin turgor) , sunken eyes, muscle cramps (decreased potassium), and decreased urine output.

Laboratory Findings

Lab tests are not mandatory for diagnosis and treatment of cholera. In endemic areas when suspected, treatment should be started as early as possible with fluid replacement and antibiotics. In areas where cholera is uncommon, performing lab tests are worthwhile.Tests used for identification of organisms are: Direct microscopic examination of organism, dark field examination, gram staining, culture, antigen, polymerase chain reaction and serotype tests.

Treatment

Medical Therapy

In most cases, cholera can be successfully treated with oral rehydration therapy (ORT), which is highly effective, safe, and simple to administer. In severe cases with significant dehydration, intravenous rehydration may be necessary. Ringer's lactate is the preferred solution, often with added potassium.[11][13] Large volumes and continued replacement until diarrhea has subsided may be needed.[11] Ten percent of a person's body weight in fluid may need to be given in the first two to four hours.[11] Antibiotic treatments for one to three days shorten the course of the disease and reduce the severity of the symptoms. People can recover even without them, if sufficient hydration and electrolyte balance is maintained. Doxycycline is typically used first line, although some strains of V. cholerae have shown resistance.

Primary Prevention

Although cholera can be life-threatening, it is nearly always easily prevented, in principle, if proper sanitation practices are followed. In the United States and Western Europe, because of advanced water treatment and sanitation systems, cholera is no longer a major threat. The last major outbreak of cholera in the United States was in 1911. However, everyone, especially travelers, should be aware of how the disease is transmitted and what can be done to prevent it. Good sanitation practices, if instituted in time, are usually sufficient to stop an epidemic.

References

  1. Rosenberg, Charles E. (1987). The cholera years: the United States in 1832, 1849 and 1866. Chicago: University of Chicago Press. ISBN 0-226-72677-0.
  2. Hartwell LH, Hood L, Goldberg ML, Reynolds AE, Silver LM, and Veres RC (2004). Genetics: From Genes to Genomes. Mc-Graw Hill, Boston: p. 551-552, 572-574 (using the turning off and turning on of gene expression to make toxin proteins in cholera bacteria as a "comprehensive example" of what is known about the mechanisms by which bacteria change the mix of proteins they manufacture to respond to the changing opportunities for surviving and thriving in different chemical environments).
  3. 3.0 3.1 Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. pp. 376&ndash, 7. ISBN 0838585299.
  4. Reidl J, Klose KE (2002). "Vibrio cholerae and cholera: out of the water and into the host". FEMS Microbiol. Rev. 26 (2): 125–39. doi:10.1111/j.1574-6976.2002.tb00605.x. PMID 12069878. Unknown parameter |month= ignored (help)
  5. Sack DA, Sack RB, Chaignat CL (2006). "Getting serious about cholera". N. Engl. J. Med. 355 (7): 649–51. doi:10.1056/NEJMp068144. PMID 16914700. Unknown parameter |month= ignored (help)
  6. Blake, PA (1993). "Epidemiology of cholera in the Americas". Gastroenterology clinics of North America. 22 (3): 639–60. PMID 7691740.
  7. Glass RI, Holmgren J, Haley CE, Khan MR, Svennerholm AM, Stoll BJ; et al. (1985). "Predisposition for cholera of individuals with O blood group. Possible evolutionary significance". Am J Epidemiol. 121 (6): 791–6. PMID 4014172.
  8. Rabbani GH, Greenough WB (1999). "Food as a vehicle of transmission of cholera". J Diarrhoeal Dis Res. 17 (1): 1–9. PMID 10892490.
  9. Larocque RC, Sabeti P, Duggal P, Chowdhury F, Khan AI, Lebrun LM; et al. (2009). "A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population". Genes Immun. 10 (3): 267–72. doi:10.1038/gene.2009.2. PMC 2672110. PMID 19212328.
  10. 10.0 10.1 World Health Organization. Assessing the Outbreak response and improving preparedness (2004) http://apps.who.int/iris/bitstream/10665/43017/1/WHO_CDS_CPE_ZFk_2004.4_eng.pdf
  11. 11.0 11.1 11.2 11.3 Sack DA, Sack RB, Nair GB, Siddique AK (2004). "Cholera". Lancet. 363 (9404): 223–33. doi:10.1016/S0140-6736(03)15328-7. PMID 14738797. Unknown parameter |month= ignored (help)
  12. Todar, Kenneth. "Vibrio cholerae and Asiatic Cholera". Todar's Online Textbook of Bacteriology. Retrieved 2010-12-20.
  13. THE TREATMENT OF DIARRHOEA, A manual for physicians and other senior health workers, World Health Organization, 2005. See page 10 (14 in PDF) and esp chapter “5. MANAGEMENT OF SUSPECTED CHOLERA,” pages 16-17 (20-21 in PDF).

Template:WikiDoc Sources